|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| OTHER ASSETS | ||||||||||||||||||||
| Right of first refusal agreement cost (less accumulated amortization of $25,000 and $25,000) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIENCY | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Accrued officers’ compensation | ||||||||||||||||||||
| Loans payable to related parties | ||||||||||||||||||||
| Notes payable to third parties | ||||||||||||||||||||
| Note default penalties and interest | ||||||||||||||||||||
| Total current liabilities and total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ (DEFICIENCY) | ||||||||||||||||||||
| Preferred shares value | ||||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||||||||
| Total preferred shares value | ||||||||||||||||||||
| Common stock; 2,000,000,000 shares authorized, $.001 par value, as of June 30, 2026 and December 31, 2025, there are 994,379 and 944,935 shares outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ (deficiency) | ||||||||||||||||||||
| Total liabilities and stockholders’ (deficiency) | ||||||||||||||||||||
Loading...
